“Conclusion” from the “L.O.M. Opportunity” Document

Medical syringes and blood collection devices are a multi-billion dollar industry and “Smart” retractable syringes and blood collection devices are becoming mandatory. LOM “Smart” technology has received outstanding reviews from several of the largest medical device companies. LOM is only months away from introducing the 3 mL retractable syringe which is the first of several size syringes and two blood collection devices. LOM will then have reached the stage that attracts medical device companies to either enter into distribution agreements or purchase the Intellectual properties. Either avenue allows LOM to provide a significant return on investment to their shareholders in the near future.”

Debbie Ulansky – Investor Relations